Covid Treatment | Image of Vaccine and Needles

Phlow Lands $354M Government Contract for COVID-19 Medications

Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response.

Richmond, Va.-based Phlow’s manufacturing is being funded by the Biomedical Advanced Research and Development Authority, part of the office of Assistant Secretary for Preparedness and Response at the U.S. Dept. of Health and Human Services.


Brought to you by Fomat Medical

Add a Comment

Your email address will not be published. Required fields are marked *